Harvard University's Office of Technology Development (OTD), Nanosys, Inc., and Vista Therapeutics, Inc. today announced that Vista has signed License Agreements with both Harvard University and Nanosys covering several patents and patent applications related to the use of nanowires for biosensors.
Research and Markets has announced the addition of WinterGreen Research, Inc.'s new report "Worldwide Nanotechnology Electric Vehicle (EV) Market Shares, Strategies, and Forecasts, 2009 to 2015" to their offering.
Oerlikon Solar and Sun Well Solar, a subsidiary of CMC Magnetics, announced today that the ramp-up of the 40 MW amorphous thin film silicon production line has been completed one month ahead of schedule.
Integran Technologies Inc., a world leader in the development and commercialization of advanced metallurgical nano-technologies, has announced today that it has entered into a collaborative research agreement with TransCanada Corporation and NOVA Research and Technology Corporation to develop an in-field repair process that utilizes nanocrystalline metals to structurally reinforce degraded gas pipeline steel.
CVD Equipment Corporation announces the introduction of a family of EasyTube Systems with a focus on Quality Control and Research and Development for next generation process development in the Solar and Energy fields aimed at reducing the global dependence on oil and gas.
Carbon Sciences Inc., the developer of a breakthrough technology to transform carbon dioxide (CO2) emissions into gasoline and other fuels, announced the filing of the first in a series of patent applications protecting the company's novel and highly scalable biocatalytic process to transform CO2 into liquid fuels.
NanoBio Corp., a biopharmaceutical company developing dermatological products, anti-infective treatments and intranasal vaccines, announced today that it has acquired $12 million in series B equity financing with Perseus LLC and other existing investors.
APR Applied Pharma Research announces the acquisition of a new platform technology consisting of a patented Nanocoating process for the preparation of new patent protected biotechnology products for the treatment of several critical diseases in multiple therapeutic areas.